Clinical trials
Osteosarcoma trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 8 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Ruijin Hospital | 2 |
| Shanghai Yunying Medical Technology | 2 |
| Sun Yat-sen University | 2 |
| Base Therapeutics (Shanghai) Co., Ltd. | 1 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
| Henan Cancer Hospital | 1 |
| Lee's Pharmaceutical Limited | 1 |
| Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteosarcoma | 24 |
| Sarcoma | 3 |
| Bone Neoplasms | 2 |
| Disease Progression | 2 |
| Sarcoma, Ewing | 2 |
| Cardiotoxicity | 1 |
| Chondrosarcoma | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Hypersensitivity | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.